S. Haifa¶
At a Glance
| Antigenic Formula | 1,4,[5],12:z10:1,2 |
| Serogroup | O:4 (B) |
| NCBI Pathogen Detection | View isolates |
Background Information¶
Salmonella enterica subsp. enterica serovar Haifa (antigenic formula 1,4,[5],12:z10:1,2) is a serovar of the group O:4 (B) serogroup. This serovar was first isolated from the feces of a 3-year-old Arabic child with enteritis in 1949 in Israel. It was linked to a case of fatal food intoxication in Japan.
Genetic Characteristics¶
Serovar Haifa has been found to be monophyletic. Salmonella Haifa isolates with blaOXA-48-likewas reported in Malta. SGI1 (Salmonella genomic island 1) variants have been identified in at least two additional Salmonella serotypes, Newport and Haifa, both isolated in Egypt. In an Egyptian study, a single Haifa isolate was identified as positive for theinvA gene.
Animal Reservoir¶
Unknown but serovar Haifa was isolated from cattle, poultry, and pigs.
Geographical Distribution¶
Although serovar Haifa is rare, it has been occasionally reported worldwide.
Human/Animal Outbreaks¶
There have been no recent human outbreaks linked to serovar Haifa.
Border Rejections¶
There have been no recent border rejections linked to this serovar.
Recalls¶
There have been no recent recalls linked to this serovar.
References¶
- https://pmc.ncbi.nlm.nih.gov/articles/PMC385844/
- https://www.jstage.jst.go.jp/article/yoken/58/3/58_JJID.2005.192/_article
- https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1547190/full
- https://www.ecdc.europa.eu/sites/default/files/documents/SALM_AER_2022_Report.pdf
- https://academic.oup.com/jid/article/204/5/675/799881
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6702568/